Scientific Program
Time | Room A [English] |
|
---|---|---|
08:20-08:30 | Opening and Course Introduction | |
08:30-09:10 | Keynote Lectures | Chairperson: Seung-Woo Park (Korea) |
08:30-08:50 | TAVI in Young Patients: Ready for Prime Time | Patrizio Lancellotti (Belgium) |
08:50-09:10 | Transcatheter Tricuspid Repair Technologies: The Present and the Future | Shih-Hsien Sung (Taiwan) |
09:10-10:40 | HEART TEAM AT WORK: Decision Making for Challenging Cases (II) | Chairperson: Jae K Oh (USA), Byung Chul Chang (Korea) |
09:10-09:15 | Case Presentation (ViV for Mitral Bioprosthetic Failure) (Prepared by Korea Univ.) | So Ree Kim (Korea) |
09:15-09:25 | TMViV: Imaging Considerations | Seong-Mi Park (Korea) |
09:25-09:35 | TMViV: Interventional Considerations | Ju Hyeon Kim (Korea) |
09:35-09:50 | Heart Team Discussion | Suryeun Chung (Korea), Ik Jun Choi (Korea), Hee-Jung Kim (Korea), Hyuck-Jun Yoon (Korea) |
09:50-09:55 | Back to the Case (Slide + Recorded Video) | So Ree Kim (Korea) |
09:55-10:00 | Case Presentation (T-TEER) (Prepared by Singapore & Severance) | See Hooi Ewe (Singapore) |
10:00-10:10 | TEER for TV: Imaging Considerations | Eustachio Agricola (Italy) |
10:10-10:20 | TEER for TV: Interventional Considerations | Shunsuke Kubo (Japan) |
10:20-10:35 | Heart Team Discussion | Suryeun Chung (Korea), Ik Jun Choi (Korea), Hee-Jung Kim (Korea), Hyuck-Jun Yoon (Korea) |
10:35-10:40 | Back to the Case (Slide + Recorded Video) | See Hooi Ewe (Singapore) |
10:40-11:00 | Coffee Break | |
11:00-12:30 | Hot Topics in Tricuspid Valve Intervention | Chairpersons: June-Hong Kim (Korea), Nozomi Watanabe (Japan) |
11:00-11:15 | The Imaging for Tricuspid Interventions: What We Need to Know From the Anatomy to Function? | Sung-Ji Park (Korea) |
11:15-11:30 | Surgical Treatment of Severe TR | Joon Bum Kim (Korea) |
11:30-11:45 | Patient Selection for T-TEER: Anatomical & Technical Consideration | Shih-Hsien Sung (Taiwan) |
11:45-12:00 | T-TEER Imaging to Optimize Procedure Success | Alex Lee (Hong Kong) |
12:00-12:15 | Challenging Candidates for TEER and New Solutions | Jae Hyeong Park (Korea) |
12:15-12:30 | Panel discussion | Nurjanar Galimkhan (Mongolia), Karlie Li-Tan Yang (Taiwan), Ana Lascu (Romania), Hwan Wook Kim (Korea) |
12:30-13:30 | Luncheon Session (Edwards) | Chairpersons: Kee-Sik Kim (Korea) |
12:30-12:45 | Do Post Procedural Gradients Result in Changes in Clinical Outcomes? | Dee Dee Wang (USA) |
12:45-13:00 | Aortic Valve-in-Valve: Challenges and Innovations | Simon Lam (Hong Kong) |
13:30-15:05 | Hot Issues in Aortic Valve Intervention | Chairperson: Mani A Vannan (USA), Namsik Chung (Korea) |
13:30-13:45 | Self-Expanding Versus Balloon-Expandable TAVR in Patients with Aortic Stenosis and Small Aortic Annuli: Hemodynamic Perspectives | Jae K Oh (USA) |
13:45-14:00 | TAVR in Moderate AS & Bicuspid AV | Young-Guk Ko (Korea) |
14:00-14:15 | Current Update in ViV, TAVR in TAVR | Martin Swaans (Netherlands) |
14:15-14:30 | Surgical Removal of a TAVR Valve | Seung Hyun Lee (Korea) |
14:30-14:45 | TAVR in AR: Where Are We Now? | Karlie Li-Tan Yang (Taiwan) |
14:45-15:05 | Panel Discussion |
See Hooi Ewe (Singapore), Chi Young Shim (Korea), Taek kyu Park (Korea), Carlos Astudillo (Chile) |
15:05-15:20 | Coffee Break | |
15:20-16:55 | Essentials & Tips for Other SHD Intervention | Chairpersons: Jo Won Jung (Korea), Suhaini B Kadiman (Malaysia) |
15:20-15:40 | ASD Closure | Jae-Young Choi (Korea) |
15:40-16:00 | VSD Closure | Chang Sin Kim (Korea) |
16:00-16:20 | PFO closure | Woong Chol Kang (Korea) |
16:20-16:40 | PMV | Jung-Sun Kim (Korea) |
16:40-16:55 | Panel Discussion | Nozomi Watanabe (Japan), Le Minh Khoi (Vietnam), Kyung Eun Ha (Korea), Sang Shin Park (Korea) |
16:55 | Closing Remark | Geu-Ru Hong (Korea) |
Time | Room B (Structural Heart Disease Bootcamp) [Korean] |
|
---|---|---|
09:10-10:40 | Operating Room Spotlight | 김경환 (서울의대), 박승우 (성균관의대) |
09:10-09:30 | Chronicles of Surgical Valves | 이승현 (연세의대) |
09:30-09:50 | Chronicles of Surgical Techniques for Valvular Heart Disease | 황호영 (서울의대) |
09:50-10:05 | What's Happening in the OR during VHD Surgery: From Entry to Exit | 김준범 (울산의대) |
10:05-10:20 | As a Valve Surgeon: My Expectations from Imaging Cardiologists | 홍준화 (중앙의대) |
10:20-10:40 | Panel Discussion | 황지원 (인제의대), 이상현 (부산의대), 조인정 (이화의대), 김희동 (순천향의대) |
10:40-11:00 | Coffee Break | |
11:00-12:30 | Hybrid Room Collaboration #3:TAVR | 유승기 (이화의대), 고영국 (연세의대) |
11:00-11:15 | Before the Hybrid: Pre-TAVR Evaluation in CT Lab | Abdul Ihdayhid (Australia) |
11:15-11:30 | Interventionist's Perspective: Essential Techniques and Practices | 이오현 (연세의대) |
11:30-11:45 | Imaging Cardiologist's Perspective: Evaluation for TAVR Outcome with ICE, TTE, and TEE | 조동혁 (고려의대) |
11:45-12:00 | TAVR Complications: How I Swept Up the Mess and How It Could Have Been Prevented | 제형곤 (부산의대) |
12:00-12:15 | Recorded Live Case | 최연직 (가톨릭의대) |
12:15-12:30 | Panel Discussion | 황병희 (가톨릭의대), 박택규 (성균관의대), 김기림 (연세의대), 박준빈 (서울의대) |
12:30-13:30 | Luncheon Session (Sanofi) | 강승호 (제주한라병원) |
12:30-12:45 | Dose Matters: Optimizing Dosing Strategies of Fabrazyme for Fabry Patients |
배은희 (전남의대) |
12:45-13:00 | Leveraging Real-World Evidence: Fabrazyme's Irreplaceable Value for Fabry Patients | 김경희 (세종병원) |
13:30-15:05 | Great Debates in Structural Heart Disease #2 | 송재관 (울산의대), 신준한 (아주의대) |
13:30-13:35 | Introduction: Resolving Discrepancies in Valvular Stenosis Evaluation | 김규 (연세의대) |
13:35-13:45 | Gradient Should Be the Primary Indicator | 정혜문 (경희의대) |
13:45-13:55 | Area is the More Reliable Measure | 이상현 (부산의대) |
13:55-14:10 | Expert Panel Discussion | 김인철 (계명의대), 박재형 (충남의대), 황호영 (서울의대), 장정윤 (경상의대) |
14:10-14:15 | Wrap up and Voting | |
14:15-14:20 | Introduction: Antibiotic Prophylaxis for Endocarditis: Should It Be Extended to Other Valve Diseases and Procedures? | 고규용 (인제의대) |
14:20-14:30 | Extending Prophylaxis | 손장원 (영남의대) |
14:30-14:40 | Against Extending Prophylaxis | 서지원 (연세의대) |
14:40-14:55 | Expert Panel Discussion | 김인철 (계명의대), 박재형 (충남의대), 황호영 (서울의대), 장정윤 (경상의대) |
14:55-15:05 | Wrap up and Voting | |
15:05-15:20 | Coffee Break | |
15:20-16:55 | Top 5 Things Series: SHD Patient Evaluation | 도준형 (인제의대), 손일석 (경희의대) |
15:20-15:35 | Top 5 Things: Mechanical Valve Evaluation | 김형윤 (세종병원) |
15:35-15:50 | Top 5 Things: Bioprosthetic Valve/TEER Evaluation | 정우백 (가톨릭의대) |
15:50-16:05 | Top 5 Things: Post-LAAO Evaluation | 김혜미 (중앙의대) |
16:05-16:20 | Top 5 Things: Post-LVAD, ECMO Evaluation | 김다래 (성균관의대) |
16:20-16:35 | Top 5 Things: Heart Transplantation Evaluation | 김인철 (계명의대) |
16:35-16:55 | Panel Discussion | 이오현 (연세의대), 김시훈 (을지의대), 윤세정 (국민건강보험), 윤상곤 (연세의대) |
Time | Room C (Rare Disease) [Korean] | |
---|---|---|
12:30-13:30 | Luncheon Session (Handok) | 신미승 (가천의대) |
12:30-12:45 | When to Consider Galafold®: Right Patient, Right Treatment | 손장원 (영남의대) |
12:45-13:00 | Latest Updates in Improving Compliance and QoL in Fabry Patients |
문인기 (순천향의대) |
13:30-15:00 | Update in Fabry Disease | 김우식 (경희의대), 김영대 (동아의대) |
13:30-13:45 | How Can We Diagnose Fabry Disease Earlier? | 김경희 (세종병원) |
13:45-14:00 | Multimodal Imaging for Evaluating Treatment Response in Fabry Cardiomyopathy | 곽서연 (연세의대) |
14:00-14:15 | Immunogenicity and Antibody Formation in Fabry Disease | 이주희 (충북의대) |
14:15-14:30 | Fabry Disease in China: Current Status & Future Perspective | Zhe-Hao Piao (China) |
14:30-15:00 | Discussion | 남종호 (영남의대), 김대영 (인하의대), 임상엽 (고려의대_안산), 이수용(양산부산대) |
15:00-15:20 | Coffee Break | |
15:20-16:35 | Update in Cardiac Amyloidosis & Sarcoidosis | 홍그루 (연세의대), 정중화 (조선의대) |
15:20-15:35 | When to Suspect Cardiac Amyloidosis & Sarcoidosis in Every-day Practice? | 김민정 (이화의대) |
15:35-15:50 | Update on Diagnosis of ATTR Cardiac Amyloidosis | 문인기 (순천향의대) |
15:50-16:05 | Recent Update in Diagnosis and Management of Cardiac Sarcoidosis? | 박성미 (고려의대) |
16:05-16:20 | New and Emerging Treatment Options for Cardiac Amyloidosis | 최강운 (영남의대) |
16:20-16:35 | Discussion | 이수연 (세종병원), 조하혜 (울산의대), 박상현 (을지의대), 박정랑 (경상의대) |